The main hypothesis for the pathophysiology of immune thrombotic thrombocytopenia induced by an adenoviral vector-based COVID-19 vaccine involves the reaction between cationic platelet factor 4 (PF4) and anionic-free DNA in the recombinant adenovirus vaccine [72]. This evidence concerns the gene PF4 and COVID-19.